China Risun Group (01907) rose more than 5% in afternoon trading. At the time of writing, the stock was up 5.52%, trading at HK$3.25 with a turnover of HK$113 million. The company announced earlier this month that its self-developed adiponitrile production unit using caprolactam completed catalyst loading on March 30, 2026, laying the groundwork for commencement of operations in April. Full-year production for 2026 is estimated to reach approximately 30,000 tonnes. Debon Securities noted that with the ongoing Middle East geopolitical crisis driving a significant increase in international crude oil prices, the company's chemical products business is expected to see corresponding price surges. For instance, market prices for methanol and caprolactam by late March had risen over 60% and 30%, respectively, compared to the beginning of the year. The firm's years of strategic investments may soon yield substantial returns.